Clinical Presentation, Molecular Profile, Demographics, and Risk Stratification of Myeloproliferative Neoplasms Presenting in Pakistan

Authors

  • Arwa Arshad Hemato-oncology Department, INMOL Cancer Hospital, Lahore
  • Rija Tariq Hemato-oncology Department, INMOL Cancer Hospital, Lahore
  • Nadia Sajid
  • Nawwal Naeem
  • Hina Tahir

Abstract

Objective: To determine the epidemiology and clinical characteristics of Myeloproliferative disorders presenting in Pakistan and to draw comparisons with western population.

Methodology: This cross-sectional observational study was conducted at the Hemato-oncology Department, INMOL Cancer Hospital, Lahore from 15 November 2025 till 15 May 2026.

A total of 163 patients were included in the study by non-probability consecutive sampling. The patients were diagnosed using WHO criteria as Philadelphia chromosome negative MPNs and CML cases. Clinical, laboratory, and molecular data were noted. Data was analyzed using SPSS version 26. Quantitative variables were expressed as mean ± standard deviation, while qualitative variables were presented as frequencies and percentages.

Results: A total of 163 patients were included in the study. Of these, 93 patients were diagnosed with Ph Chromosome negative myeloproliferative neoplasms (MPNs) and 70 patients were diagnosed with CML. Among the 93 MPNs cases, 58 (62.4%) were males and 35 (37.6%) were females. The age of the patients ranged from 19 to 72 years, with a mean age of 46.7 ± 15.2 years. The most frequently diagnosed subtype was essential thrombocythemia (ET) in 41 (44.1%) patients, followed by myelofibrosis (MF) in 29 (31.2%) and polycythemia Vera (PV) in 23 (24.7%) cases. 7 (7.5%) patients experienced AKI as complication in the Ph chromosome negative MPNs. In the 70 CML cases, 43 (61.4%) patients were male while 27 (38.5%) were female. The age of patients ranged from 10 to 70 years with a mean age of 40.2 ± 2.8 years.

Conclusion: The majority of MPNs have demonstrated a distinct pattern with a younger age of presentation and significant molecular associations. The variations with Western data emphasize regional variability and need for improved diagnostics

Downloads

Published

2026-10-09

Issue

Section

Original Article